Clinical laboratory response to a mock outbreak of invasive bacterial infections: A preparedness study

Journal of Clinical Microbiology

Volumn 52, Issue 12, 2014, Pages 4210-4216

  Olsen, Randall J ^a,b   Fittipaldi, Nahuel ^c,d   Kachroo, Priyanka ^a,b   Sanson, Misu A ^a,b,e   Long, S Wesley ^a,b   Como Sabetti, Kathryn J ^f   Valson, Chandni ^a,b   Cantu, Concepcion ^a,b   Lynfield, Ruth ^f   Van Beneden, Chris ^g   Beres, Stephen B ^a,b   Musser, James M ^a,b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c PUBLIC HEALTH ONTARIO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e ESCUELA DE MEDICINA Y CIENCIAS DE LA SALUD   (Mexico)

^f MINNESOTA DEPARTMENT OF HEALTH   (United States)

^g NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; CLINICAL LABORATORY; EPIDEMIC; GENE EXPRESSION; HASA GENE; HASB GENE; HASC GENE; NONHUMAN; PHYLOGENETIC TREE; PHYLOGENY; RAPID RESPONSE TEAM; SEQUENCE ANALYSIS; SEROTYPE EMM59 GROUP A STREPTOCOCCUS; STREPTOCOCCUS GROUP A; TRANSCRIPTOMICS; UNITED STATES; WHOLE GENOME SEQUENCING; YESM GENE; YESN GENE; ANIMAL; CANADA; CIVIL DEFENSE; CLASSIFICATION; DISEASE MODEL; GENE EXPRESSION PROFILING; GENETICS; GOOD LABORATORY PRACTICE; HEALTH SERVICES RESEARCH; HIGH THROUGHPUT SEQUENCING; HUMAN; ISOLATION AND PURIFICATION; MOLECULAR DIAGNOSIS; MOUSE; PROCEDURES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

ANIMALS; CANADA; CIVIL DEFENSE; DISEASE MODELS, ANIMAL; DISEASE OUTBREAKS; GENE EXPRESSION PROFILING; GENOME, BACTERIAL; HEALTH SERVICES RESEARCH; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LABORATORY PROFICIENCY TESTING; MICE; MOLECULAR DIAGNOSTIC TECHNIQUES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; UNITED STATES;

EID: 84910145818     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02164-14     Document Type: Article

References (26)

1. Harris SR, Cartwright EJ, Török ME, Holden MT, Brown NM, Ogilvy-Stuart AL, Ellington MJ, Quail MA, Bentley SD, Parkhill J, Peacock SJ. 2013. Whole-genome sequencing for analysis of an outbreak of meticillinresistant Staphylococcus aureus: a descriptive study. Lancet Infect. Dis. 13:130-136. http://dx.doi.org/10.1016/S1473-3099(12)70268-2.
2. Walker TM, Ip CL, Harrell RH, Evans JT, Kapatai G, Dedicoat MJ, Eyre DW, Wilson DJ, Hawkey PM, Crook DW, Parkhill J, Harris D, Walker AS, Bowden R, Monk P, Smith EG, Peto TE. 2013. Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect. Dis. 13:137-146. http://dx.doi.org/10.1016/S1473-3099(12)70277-3.
3. Rasko DA, Webster DR, Sahl JW, Bashir A, Boisen N, Scheutz F, Paxinos EE, Sebra R, Chin CS, Iliopoulos D, Klammer A, Peluso P, Lee L, Kislyuk AO, Bullard J, Kasarskis A, Wang S, Eid J, Rank D, Redman JC, Steyert SR, Frimodt-Møller J, Struve C, Petersen AM, Krogfelt KA, Nataro JP, Schadt EE, Waldor MK. 2011. Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany. N. Engl. J. Med. 365:709-717. http://dx.doi.org/10.1056/NEJMoa1106920.
4. Long SW, Williams D, Valson C, Cantu CC, Cernoch P, Musser JM, Olsen RJ. 2013. A genomic day in the life of a clinical microbiology laboratory. J. Clin. Microbiol. 51:1272-1277. http://dx.doi.org/10.1128/JCM.03237-12.
5. Wright AM, Beres SB, Consamus EN, Long SW, Flores AR, Barrios R, Richter GS, Oh SY, Garufi G, Maier H, Drews AL, Stockbauer KE, Cernoch P, Schneewind O, Olsen RJ, Musser JM. 2011. Rapidly progressive, fatal, inhalation anthrax-like infection in a human: case report, pathogen genome sequencing, pathology, and coordinated response. Arch. Pathol. Lab. Med. 135:1447-1459. http://dx.doi.org/10.5858/2011-0362-SAIR.1.
6. Köser CU, Bryant JM, Becq J, Török ME, Ellington MJ, Marti-Renom MA, Carmichael AJ, Parkhill J, Smith GP, Peacock SJ. 2013. Wholegenome sequencing for rapid susceptibility testing of M. tuberculosis. N. Engl. J. Med. 369:290-292. http://dx.doi.org/10.1056/NEJMc1215305.
7. Tyrrell GJ, Lovgren M, Ibrahim Q, Garg S, Chui L, Boone TJ, Mangan C, Patrick DM, Hoang L, Horsman GB, Van Caeseele P, Marrie TJ. 2012. Epidemic of invasive pneumococcal disease, western Canada, 2005-2009. Emerg. Infect. Dis. 18:733-740. http://dx.doi.org/10.3201/eid1805.110235.
8. Steer AC, Law I, Matatolu L, Beall BW, Carapetis JR. 2009. Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect. Dis. 9:611-616. http://dx.doi.org/10.1016/S1473-3099(09)70178-1.
9. Shea PR, Ewbank AL, Gonzalez-Lugo JH, Martagon-Rosado AJ, Martinez-Gutierrez JC, Rehman HA, Serrano-Gonzalez M, Fittipaldi N, Beres SB, Flores AR, Low DE, Willey BM, Musser JM. 2011. Group A streptococcus emm gene types in pharyngeal isolates, Ontario, Canada, 2002-2010. Emerg. Infect. Dis. 17:2010-2017. http://dx.doi.org/10.3201/eid1711.110159.
10. Fittipaldi N, Beres SB, Olsen RJ, Kapur V, Shea PR, Watkins ME, Cantu CC, Laucirica DR, Jenkins L, Flores AR, Lovgren M, Ardanuy C, Liñares J, Low DE, Tyrrell GJ, Musser JM. 2012. Full-genome dissection of an epidemic of severe invasive disease caused by a hypervirulent, recently emerged clone of group A streptococcus. Am. J. Pathol. 180:1522-1534. http://dx.doi.org/10.1016/j.ajpath.2011.12.037.
11. Fittipaldi N, Olsen RJ, Beres SB, Van Beneden C, Musser JM. 2012. Genomic analysis of emm59 group A streptococcus invasive strains, United States. Emerg. Infect. Dis. 18:650-652. http://dx.doi.org/10.3201/eid1804.111803.
12. Fittipaldi N, Tyrrell GJ, Low DE, Martin I, Lin D, Hari KL, Musser JM. 2013. Integrated whole-genome sequencing and temporospatial analysis of a continuing group A streptococcus epidemic. Emerg. Microbes Infect. 2:e13. http://dx.doi.org/10.1038/emi.2013.13.
13. Centers for Disease Control and Prevention. 2013. Active Bacterial Core Surveillance (ABCs) report. Emerging Infections Program Network:group A Streptococcus, 2012. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/abcs/reports-findings/survreports/gas12.pdf.
14. Athey TB, Teatero S, Li A, Marchand-Austin A, Beall BW, Fittipaldi N. 2014. Deriving groupAstreptococcus typing information from short-read whole-genome sequencing data. J. Clin. Microbiol. 52:1871-1876. http://dx.doi.org/10.1128/JCM.00029-14.
15. Nasser W, Beres SB, Olsen RJ, Dean MA, Rice KA, Long SW, Kristinsson KG, Gottfredsson M, Vuopio J, Raisanen K, Caugant DA, Steinbakk M, Low DE, McGeer A, Darenberg J, Henriques-Normark B, Van Beneden CA, Hoffmann S, Musser JM. 2014. Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences. Proc. Natl. Acad. Sci. U. S. A. 111:E1768-E1776. http://dx.doi.org/10.1073/pnas.1403138111.
16. Brown CC, Olsen RJ, Fittipaldi N, Mormon ML, Fort PL, Neuwirth R, Majeed M, Woodward WB, Musser JM. 2014. Spread of virulent group A Streptococcus type emm59 from Montana to Wyoming, USA. Emerg. Infect. Dis. 20:658-660. http://dx.doi.org/10.3201/eid2004.130564.
17. Beres SB, Musser JM. 2007. Contribution of exogenous genetic elements to the group A Streptococcus metagenome. PLoS One 2:e800. http://dx.doi.org/10.1371/journal.pone.0000800.
18. Hause LL, McIver KS. 2012. Nucleotides critical for the interaction of the Streptococcus pyogenes Mga virulence regulator with Mga-regulated promoter sequences. J. Bacteriol. 194:4904-4919. http://dx.doi.org/10.1128/JB.00809-12.
19. Sumby P, Zhang S, Whitney AR, Falugi F, Grandi G, Graviss EA, Deleo FR, Musser JM. 2008. A chemokine-degrading extracellular protease made by group A streptococcus alters pathogenesis by enhancing evasion of the innate immune response. Infect. Immun. 76:978-985. http://dx.doi.org/10.1128/IAI.01354-07.
20. Wessels MR, Moses AE, Goldberg JB, DiCesare TJ. 1991. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc. Natl. Acad. Sci. U. S. A. 88:8317-8321. http://dx.doi.org/10.1073/pnas.88.19.8317.
21. Sitkiewicz I, Musser JM. 2006. Expression microarray and mouse virulence analysis of four conserved two-component gene regulatory systems in group a streptococcus. Infect. Immun. 74:1339-1351. http://dx.doi.org/10.1128/IAI.74.2.1339-1351.2006.
22. Safronetz D, Rockx B, Feldmann F, Belisle SE, Palermo RE, Brining D, Gardner D, Proll SC, Marzi A, Tsuda Y, Lacasse RA, Kercher L, York A, Korth MJ, Long D, Rosenke R, Shupert WL, Aranda CA, Mattoon JS, Kobasa D, Kobinger G, Li Y, Taubenberger JK, Richt JA, Parnell M, Ebihara H, Kawaoka Y, Katze MG, Feldmann H. 2011. Pandemic swine-origin H1N1 influenza A virus isolates show heterogeneous virulence in macaques. J. Virol. 85:1214-1223. http://dx.doi.org/10.1128/JVI.01848-10.
23. Olsen RJ, Long SW, Musser JM. 2012. Bacterial genomics in infectious disease and the clinical pathology laboratory. Arch. Pathol. Lab. Med. 136:1414-1422. http://dx.doi.org/10.5858/arpa.2012-0025-RA.
24. Long SW, Olsen RJ, Mehta SC, Palzkill TG, Cernoch PL, Perez KK, Musick WL, Rosato AE, Musser JM. 25 August 2014. PBP2a mutations causing high-level ceftaroline resistance in clinical methicillin-resistant Staphylococcus aureus isolates. Antimicrob. Agents Chemother. http://dx.doi.org/10.1128/AAC.03622-14.
25. Eppinger M, Mammel MK, Leclerc JE, Ravel J, Cebula TA. 2011. Genomic anatomy of Escherichia coli O157:H7 outbreaks. Proc. Natl. Acad. Sci. U. S. A. 108:20142-20147. http://dx.doi.org/10.1073/pnas.1107176108.
26. Deleo FR, Chen L, Porcella SF, Martens CA, Kobayashi SD, Porter AR, Chavda KD, Jacobs MR, Mathema B, Olsen RJ, Bonomo RA, Musser JM, Kreiswirth BN. 2014. Molecular dissection of the evolution of carbapenem-resistant multilocus sequence type 258 Klebsiella pneumoniae. Proc. Natl. Acad. Sci. U. S. A. 111:4988-4993. http://dx.doi.org/10.1073/pnas.1321364111.